24 March 2022

COVID-19

What do we mean by covid immunity?

17 March 2022

Conditions COVID-19

Wet market ‘still covid’s most likely origin’

17 March 2022

Biologics COVID-19 Reactive Arthritis

A silver lining to sulfasalazine’s covid fear

3 March 2022

COVID-19 TGA

Access concerns for “game-changing” covid therapy

3 March 2022

Anti JAKS Biologics COVID-19 Fibromyalgia

Antipyretics ‘reduce covid immunity, help fight TB’

3 March 2022

Biologics COVID-19

Rheumatology patients share their experiences of the covid pandemic

3 March 2022

COVID-19 osteomyelitis PBS

Covid antiviral’s MTX block

17 February 2022

COVID-19 TGA

New covid treatment options for immunocompromised patients

10 February 2022

COVID-19

How variant-proof are our covid treatments?

10 February 2022

COVID-19 Research

The year ahead in rheumatology

3 February 2022

COVID-19 Gout Lupus Scleroderma

Updated covid treatment guidelines and immunosuppressed patients

3 February 2022

COVID-19

Omicron wave crashes over hospitals

27 January 2022

COVID-19

Should boosters be delayed in covid patients?

27 January 2022

Comment COVID-19

We need to talk about masks

22 December 2021

COVID-19 Gout

Rheumatology Republic Year in Review

2 December 2021

APLAR COVID-19

AHPRA flexible on mandatory CPD training